Table 2

Clinical and epidemiological characteristics of LGV-positive patients stratified by LGV variants detected

L2b
(n=15)
L2f
(n=30)
L2-L2b/D-Da (n=11)L2b variants*
(n=9)
Not typable
(n=11)
P value
Rectal symptoms9/15 (60%)23/30 (76.6%)7/11 (63.6%)6/9 (66.6%)7/11 (63.6%)0.8
Mean age (years±SD)37.6±8.839.2±11.737.9±13.040.5±9.637.4±9.20.9
HIV positivity 6/13 (46.1%)17/26 (65.4%)6/10 (60.0%)5/9 (55.5%)10/11 (90.9%)0.2
Early syphilis2/15 (13.3%)7/30 (23.3%)3/11 (27.2%)3/9 (33.3%)0/11 (0.0%)0.6
Rectal gonorrhoea6/15 (40%)10/30 (33.3%)5/11 (45.4%)1/9 (11.1%)5/11 (45.4%)0.4
  • *Including L2bV1 (n=1), L2bV2 (n=3), L2bV4 (n=3), L2b new variants (n=2).

  • †The percentages are calculated considering only the patients whose HIV status was known (n=69).

  • LGV, lymphogranuloma venereum.